Skip to main content

Table 1 Characteristics of patients whose breast cancer was diagnosed in California from 2006 to 2007

From: Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups

Race

Breast cancers, number (percentage)

Age in years, number (percentage)

Stage, number (percentage)

Size, number (percentage)

Luminal, number (percentage)

HER2-positive, number (percentage)

Triple-negative, number (percentage)

White

21,947 (66.1)

< 40: 786 (3.6)

Local: 14,161 (64.5)

≤2 cm: 13,537 (61.7)

15,713 (71.6)

3,713 (16.9)

2,521 (11.5)

  

40-49: 3,442 (15.7)

Reg/Dist: 7,737 (35.2)

> 2 cm, ≤5 cm: 6,386 (29.1)

   
  

50-59: 5,335 (24.3)

Unstaged: 49 (0.2)

> 5 cm: 1,475 (6.7)

   
  

60-69: 5,468 (24.9)

 

Not available: 549 (2.5)

   
  

≥70: 6,916 (31.5)

     

Black

2,071 (6.2)

< 40: 137 (6.6)

Local: 1,128 (54.5)

≤2 cm: 1,007 (48.6)

1,098 (53.0)

464 (22.4)

509 (24.6)

  

40-49: 474 (22.9)

Reg/Dist: 931 (45.0)

> 2 cm, ≤5 cm: 737 (35.6)

   
  

50-59: 553 (26.7)

Unstaged: 12 (0.6)

> 5 cm: 250 (12.1)

   
  

60-69: 461 (22.3)

 

Not available: 77 (3.7)

   
  

≥70: 446 (21.5)

     

Hispanic

5,523 (16.6)

< 40: 582 (10.5)

Local: 3,013 (54.6)

≤2 cm: 2,788 (50.5)

3,275 (59.3)

1,328 (24.0)

920 (16.7)

  

40-49: 1,419 (25.7)

Reg/Dist: 2,476 (44.8)

> 2 cm, ≤5 cm: 1,993 (36.1)

   
  

50-59: 1,414 (25.6)

Unstaged: 34 (0.6)

> 5 cm: 562 (10.2)

   
  

60-69: 1,092 (19.8)

 

Not available: 180 (3.3)

   
  

≥70: 1,016 (18.4)

     

Asian

3,658 (11.0)

< 40: 298 (8.1)

Local: 2,258 (61.7)

≤2 cm: 2,069 (56.6)

2,296 (62.8)

994 (27.2)

368 (10.0)

  

40-49: 910 (24.9)

Reg/Dist: 1,385 (37.9)

> 2 cm, ≤5 cm: 1,212 (33.1)

   
  

50-59: 1,057 (28.9)

Unstaged: 15 (0.4)

> 5 cm: 301 (8.2)

   
  

60-69: 712 (19.5)

 

Not available: 76 (2.1)

   
  

≥70: 681 (18.6)

     

All racesa

33,199 (100)

< 40: 1,803 (5.4)

Local: 20,560 (61.9)

≤2 cm: 19,401 (58.4)

22,382 (67.4)

6,499 (19.6)

4,318 (13)

  

40-49: 6,245 (18.8)

Reg/Dist: 12,529 (37.7)

> 2 cm, ≤5 cm: 10,328 (31.1)

   
  

50-59: 8,359 (25.2)

Unstaged: 110 (0.3)

> 5 cm: 2,588 (7.8)

   
  

60-69: 7,733 (23.3)

 

Not available: 882 (2.7)

   
  

≥70: 9,059 (27.3)

     
     

Chi-square test for subtype by race: P < 0.0001

  1. Data include age, race/ethnicity, stage (local, regional or distant [Reg/Dist], or unstaged), tumor size, and subtype: luminal (estrogen receptor [ER]- or progesterone receptor [PR]-positive or both and HER2/neu [HER2]-negative), HER2-positive (ER- and PR-positive or -negative and HER2-positive), and triple-negative (ER-negative, PR-negative, and HER2-negative). aExcludes 7,737 cases (5,069 whites, 505 blacks, 1,262 Hispanics, and 901 Asians) for whom ER, PR, or HER2 were untested, borderline, missing, or unknown.